BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 19162086)

  • 1. The occurrence of a deficit in contextual fear extinction in adult amyloid-over-expressing TASTPM mice is independent of the strength of conditioning but can be prevented by mild novel cage stress.
    Rattray I; Scullion GA; Soulby A; Kendall DA; Pardon MC
    Behav Brain Res; 2009 Jun; 200(1):83-90. PubMed ID: 19162086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels.
    Pardon MC; Sarmad S; Rattray I; Bates TE; Scullion GA; Marsden CA; Barrett DA; Lowe J; Kendall DA
    Neurobiol Aging; 2009 Jul; 30(7):1099-113. PubMed ID: 18023506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel cage stress alters remote contextual fear extinction and regional T2 magnetic resonance relaxation times in TASTPM mice overexpressing amyloid.
    Rattray I; Pitiot A; Lowe J; Auer DP; Lima SJ; Schubert MI; Prior MJ; Marsden CA; Diaz FP; Kendall DA; Pardon MC
    J Alzheimers Dis; 2010; 20(4):1049-68. PubMed ID: 20413887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease.
    Bonardi C; de Pulford F; Jennings D; Pardon MC
    Behav Brain Res; 2011 Sep; 222(1):89-97. PubMed ID: 21440575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
    Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L
    J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Pavlovian cued fear conditioning in Tg2576 mice expressing a human mutant amyloid precursor protein gene.
    Barnes P; Good M
    Behav Brain Res; 2005 Feb; 157(1):107-17. PubMed ID: 15617777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes.
    Howlett DR; Richardson JC; Austin A; Parsons AA; Bate ST; Davies DC; Gonzalez MI
    Brain Res; 2004 Aug; 1017(1-2):130-6. PubMed ID: 15261108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of synaptic transmission in the hippocampal-mPFC pathway during extinction trials of context-dependent fear memory in juvenile rat stress models.
    Koseki H; Matsumoto M; Togashi H; Miura Y; Fukushima K; Yoshioka M
    Synapse; 2009 Sep; 63(9):805-13. PubMed ID: 19504621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's disease.
    Rustay NR; Cronin EA; Curzon P; Markosyan S; Bitner RS; Ellis TA; Waring JF; Decker MW; Rueter LE; Browman KE
    Brain Res; 2010 Jan; 1311():136-47. PubMed ID: 19944081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior chronic nicotine impairs cued fear extinction but enhances contextual fear conditioning in rats.
    Tian S; Gao J; Han L; Fu J; Li C; Li Z
    Neuroscience; 2008 Jun; 153(4):935-43. PubMed ID: 18440720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor receptor 1 activation during exposure to novelty stress protects against Alzheimer's disease-like cognitive decline in AβPP/PS1 mice.
    Scullion GA; Hewitt KN; Pardon MC
    J Alzheimers Dis; 2013; 34(3):781-93. PubMed ID: 23302658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitating actions of an AMPA receptor potentiator upon extinction of contextually conditioned fear response in stressed mice.
    Yamada D; Wada K; Sekiguchi M
    Neurosci Lett; 2011 Jan; 488(3):242-6. PubMed ID: 21094221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of neurotensin type 1 receptor facilitates contextual fear memory depending on the memory strength.
    Yamada D; Wada E; Amano T; Wada K; Sekiguchi M
    Pharmacol Biochem Behav; 2010 Sep; 96(3):363-9. PubMed ID: 20600248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cognition alteration across the course of the disease in APP751SL mice with parallel estimation of cerebral Abeta deposition.
    Blanchard J; Decorte L; Noguès X; Micheau J
    Behav Brain Res; 2009 Jul; 201(1):147-57. PubMed ID: 19428628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in extinction of conditioned fear in C57BL/6 substrains are unrelated to expression of alpha-synuclein.
    Siegmund A; Langnaese K; Wotjak CT
    Behav Brain Res; 2005 Feb; 157(2):291-8. PubMed ID: 15639180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic inhibition of neuronal calcineurin activity in the forebrain facilitates fear conditioning, but inhibits the extinction of contextual fear memories.
    Havekes R; Nijholt IM; Visser AK; Eisel UL; Van der Zee EA
    Neurobiol Learn Mem; 2008 May; 89(4):595-8. PubMed ID: 17884610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficits in aversive but not in safe taste memory in the APPswe/PS1dE9 mice.
    Ramírez-Lugo L; Jensen MS; Søderman A; West MJ
    J Alzheimers Dis; 2009; 18(2):281-93. PubMed ID: 19584428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early life programming of innate fear and fear learning in adult female rats.
    Stevenson CW; Meredith JP; Spicer CH; Mason R; Marsden CA
    Behav Brain Res; 2009 Mar; 198(1):51-7. PubMed ID: 18996416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis.
    Scullion GA; Kendall DA; Marsden CA; Sunter D; Pardon MC
    Neuropharmacology; 2011; 60(2-3):223-34. PubMed ID: 20850464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related deficits in the retention of memories for cued fear conditioning are reversed by galantamine treatment.
    Gould TJ; Feiro OR
    Behav Brain Res; 2005 Dec; 165(2):160-71. PubMed ID: 16154210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.